Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
Authors:
Open Access
- 1 October 1993
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 178 (4) , 1407-1417
Abstract
The CD21/CD19/TAPA-1 complex of B lymphocytes amplifies signal transduction through membrane immunoglobulin (mIg), recruits phosphatidylinositol 3-kinase (PI3-kinase), and induces homotypic cellular aggregation. The complex is unique among known membrane protein complexes of the immune system because its components represent different protein families, and can be expressed individually. By constructing chimeric molecules replacing the extracellular, transmembrane, and cytoplasmic regions of CD19 and CD21 with those of HLA-A2 and CD4, we have determined that CD19 and TAPA-1 interact through their extracellular domains, CD19 and CD21 through their extracellular and transmembrane domains, and, in a separate complex, CD21 and CD35 through their extracellular domains. A chimeric form of CD19 that does not interact with CD21 or TAPA-1 was expressed in Daudi B lymphoblastoid cells and was shown to replicate two functions of wild-type CD19 contained within the complex: synergistic interaction with mIgM to increase intracellular free calcium and tyrosine phosphorylation and association with the p85 subunit of PI3-kinase after ligation of mIgM. The chimeric CD19 lacked the capacity of the wild-type CD19 to induce homotypic cellular aggregation, a function of the complex that can be ascribed to the TAPA-1 component. The CD21/CD19/TAPA-1 complex brings together independently functioning subunits to enable the B cell to respond to low concentrations of antigen.Keywords
This publication has 44 references indexed in Scilit:
- CD19 of B Cells as a Surrogate Kinase Insert Region to Bind Phosphatidylinositol 3-KinaseScience, 1993
- CD19: Lowering the Threshold for Antigen Receptor Stimulation of B LymphocytesScience, 1992
- Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.Journal of Experimental Medicine, 1991
- Suppression of the Immune Response by a Soluble Complement Receptor of B LymphocytesScience, 1991
- Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.Journal of Experimental Medicine, 1991
- In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.Journal of Experimental Medicine, 1990
- The lysine residue in the membrane-spanning domain of the beta chain is necessary for cell surface expression of the T cell antigen receptor.Journal of Experimental Medicine, 1988
- CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail.Journal of Experimental Medicine, 1988
- The T Cell Receptor/CD3 Complex: A Dynamic Protein EnsembleAnnual Review of Immunology, 1988
- Transmembrane signaling of interleukin 2 receptor. Conformation and function of human interleukin 2 receptor (p55)/insulin receptor chimeric molecules.Journal of Experimental Medicine, 1987